Aktiespararna has published an interview with Attana’s CEO

Report this content

In the interview, which can now be seen via Aktiespararna's YouTube channel, CEO, Teodor Aastrup, answers a number of questions and gives a short intro to Attana.

The interview was held in Swedish and answers the following questions:

  • What is your business idea?
  • What is unique about your company?
  • What are you focusing on right now?
  • Why should you invest in your company right now?

The video can be viewed via this link.

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Subscribe

Media

Media

Documents & Links